NCT00422552View on ClinicalTrials.gov

Effect of Indacaterol on Inspiratory Capacity and Lung Function in Patients With COPD Versus Placebo and Formoterol

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

September 30, 2006

Conditions

COPD

Interventions

DRUG

Indacaterol (QAB149)

Trial Locations (1)

Unknown

Novartis Investigative site, Horsham

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY